Skip to main content
Top
Published in: Critical Care 1/2013

01-02-2013 | Commentary

Protease-activated receptor-1: key player in the sepsis coagulation-inflammation crosstalk

Authors: Karim Asehnoune, Pierre Moine

Published in: Critical Care | Issue 1/2013

Login to get access

Abstract

Protease-activated receptors (PARs) belong to the family of G protein-coupled receptors. Among the four members, PAR1 plays a major role in orchestrating the interactions between coagulation and inflammation. PAR1 has opposing functions during sepsis, and PAR1 blockade or activation may be alternatively beneficial at early or late stages of different sepsis models. Studying molecular mechanisms of the crosstalk between inflammation and coagulation may lead to the identification of new targets for therapies in sepsis. However, the time-dependent switch of PAR1 from an exacerbating proinflammatory receptor to a protective anti-inflammatory receptor needs to be investigated before clinical trials can be recommended. Finally, as PAR1 seems to play a singular role in Streptococcus pneumoniae-induced sepsis through a crosstalk between PAR1 and platelet-activating factor receptor, the exact role of PAR1 needs to be investigated in other models of sepsis.
Literature
1.
go back to reference Schouten M, van't Veer C, Roelofs JJ, Levi M, van der Poll T: Protease-activated receptor-1 impairs host defense in murine pneumococcal pneumonia: a controlled laboratory study. Crit Care 2012, 16: R238. 10.1186/cc11910PubMedCentralCrossRefPubMed Schouten M, van't Veer C, Roelofs JJ, Levi M, van der Poll T: Protease-activated receptor-1 impairs host defense in murine pneumococcal pneumonia: a controlled laboratory study. Crit Care 2012, 16: R238. 10.1186/cc11910PubMedCentralCrossRefPubMed
2.
go back to reference Adams MN, Ramachandran R, Yau M-K, Suen JY, Fairlie DP, Hollenberg MD, Hooper JD: Structure, function and pathophysiology of protease activated receptors. Pharmacol Ther 2011, 130: 248-282. 10.1016/j.pharmthera.2011.01.003CrossRefPubMed Adams MN, Ramachandran R, Yau M-K, Suen JY, Fairlie DP, Hollenberg MD, Hooper JD: Structure, function and pathophysiology of protease activated receptors. Pharmacol Ther 2011, 130: 248-282. 10.1016/j.pharmthera.2011.01.003CrossRefPubMed
3.
4.
go back to reference Peters T, Henry PJ: Protease-activated receptors and prostaglandins in inflammatory lung disease. Br J Pharmacol 2009, 158: 1017-1033. 10.1111/j.1476-5381.2009.00449.xPubMedCentralCrossRefPubMed Peters T, Henry PJ: Protease-activated receptors and prostaglandins in inflammatory lung disease. Br J Pharmacol 2009, 158: 1017-1033. 10.1111/j.1476-5381.2009.00449.xPubMedCentralCrossRefPubMed
5.
go back to reference van der Poll T, Levi M: Crosstalk between inflammation and coagulation: the lessons of sepsis. Curr Vasc Pharmacol 2012, 10: 632-638. 10.2174/157016112801784549CrossRefPubMed van der Poll T, Levi M: Crosstalk between inflammation and coagulation: the lessons of sepsis. Curr Vasc Pharmacol 2012, 10: 632-638. 10.2174/157016112801784549CrossRefPubMed
6.
go back to reference Khoufache K, Berri F, Nacken W, Vogel AB, Delenne M, Camerer E, Coughlin SR, Carmeliet P, Lina B, Rimmelzwaan GF, Planz O, Ludwig S, Riteau B: PAR1 contributes to influenza A virus pathogenicity in mice. J Clin Invest 2013, 123: 206-214. 10.1172/JCI61667PubMedCentralCrossRefPubMed Khoufache K, Berri F, Nacken W, Vogel AB, Delenne M, Camerer E, Coughlin SR, Carmeliet P, Lina B, Rimmelzwaan GF, Planz O, Ludwig S, Riteau B: PAR1 contributes to influenza A virus pathogenicity in mice. J Clin Invest 2013, 123: 206-214. 10.1172/JCI61667PubMedCentralCrossRefPubMed
7.
go back to reference Jenkins RG, Su X, Su G, Scotton CJ, Camerer E, Laurent GJ, Davis GE, Chambers RC, Matthay MA, Sheppard D: Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-beta activation and promotes acute lung injury. J Clin Invest 2006, 116: 1606-1614. 10.1172/JCI27183PubMedCentralCrossRefPubMed Jenkins RG, Su X, Su G, Scotton CJ, Camerer E, Laurent GJ, Davis GE, Chambers RC, Matthay MA, Sheppard D: Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-beta activation and promotes acute lung injury. J Clin Invest 2006, 116: 1606-1614. 10.1172/JCI27183PubMedCentralCrossRefPubMed
8.
go back to reference Mercer PF, Deng X, Chambers RC: Signaling pathways involved in proteinase-activated receptor1-induced proinflammatory and profibrotic mediator release following lung injury. Ann N Y Acad Sci 2007, 1096: 86-88. 10.1196/annals.1397.073CrossRefPubMed Mercer PF, Deng X, Chambers RC: Signaling pathways involved in proteinase-activated receptor1-induced proinflammatory and profibrotic mediator release following lung injury. Ann N Y Acad Sci 2007, 1096: 86-88. 10.1196/annals.1397.073CrossRefPubMed
9.
go back to reference Chen D, Carpenter A, Abrahams J, Chambers RC, Lechler RI, McVey JH, Dorling A: Protease-activated receptor 1 activation is necessary for monocyte chemoattractant protein 1-dependent leukocyte recruitment in vivo. J Exp Med 2008, 205: 1739-1746. 10.1084/jem.20071427PubMedCentralCrossRefPubMed Chen D, Carpenter A, Abrahams J, Chambers RC, Lechler RI, McVey JH, Dorling A: Protease-activated receptor 1 activation is necessary for monocyte chemoattractant protein 1-dependent leukocyte recruitment in vivo. J Exp Med 2008, 205: 1739-1746. 10.1084/jem.20071427PubMedCentralCrossRefPubMed
10.
go back to reference Melnikova VO, Balasubramanian K, Villares GJ, Dobroff AS, Zigler M, Wang H, Petersson F, Price JE, Schroit A, Prieto VG, Hung M-C, Bar-Eli M: Crosstalk between protease-activated receptor 1 and platelet-activating factor receptor regulates melanoma cell adhesion molecule (MCAM/MUC18) expression and melanoma metastasis. J Biol Chem 2009, 284: 28845-28855. 10.1074/jbc.M109.042150PubMedCentralCrossRefPubMed Melnikova VO, Balasubramanian K, Villares GJ, Dobroff AS, Zigler M, Wang H, Petersson F, Price JE, Schroit A, Prieto VG, Hung M-C, Bar-Eli M: Crosstalk between protease-activated receptor 1 and platelet-activating factor receptor regulates melanoma cell adhesion molecule (MCAM/MUC18) expression and melanoma metastasis. J Biol Chem 2009, 284: 28845-28855. 10.1074/jbc.M109.042150PubMedCentralCrossRefPubMed
11.
go back to reference Rijneveld AW, Weijer S, Florquin S, Speelman P, Shimizu T, Ishii S, van der Poll T: Improved host defense against pneumococcal pneumonia in platelet-activating factor receptor-deficient mice. J Infect Dis 2004, 189: 711-716. 10.1086/381392CrossRefPubMed Rijneveld AW, Weijer S, Florquin S, Speelman P, Shimizu T, Ishii S, van der Poll T: Improved host defense against pneumococcal pneumonia in platelet-activating factor receptor-deficient mice. J Infect Dis 2004, 189: 711-716. 10.1086/381392CrossRefPubMed
12.
go back to reference Almansa R, Wain J, Tamayo E, Andaluz-Ojeda D, Martin-Loeches I, Ramirez P, Bermejo-Martin JF: Immunological monitoring to prevent and treat sepsis. Crit Care 2013, 17: 109. 10.1186/cc11922PubMedCentralCrossRefPubMed Almansa R, Wain J, Tamayo E, Andaluz-Ojeda D, Martin-Loeches I, Ramirez P, Bermejo-Martin JF: Immunological monitoring to prevent and treat sepsis. Crit Care 2013, 17: 109. 10.1186/cc11922PubMedCentralCrossRefPubMed
Metadata
Title
Protease-activated receptor-1: key player in the sepsis coagulation-inflammation crosstalk
Authors
Karim Asehnoune
Pierre Moine
Publication date
01-02-2013
Publisher
BioMed Central
Published in
Critical Care / Issue 1/2013
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc12502

Other articles of this Issue 1/2013

Critical Care 1/2013 Go to the issue